A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
There is limited robust data to show that the technologies improve COPD symptoms over a long follow-up period. Data collected for 1 year or more will help the committee to understand the clinical and ...